NEW YORK (GenomeWeb) – Quest Diagnostics today said that it plans to offer $1.2 billion in senior notes.

The Madison, NJ-based clinical lab firm said the offering is being made pursuant to a shelf registration filed with the US Securities and Exchange Commission. Goldman Sachs, JP Morgan Securities, Morgan Stanley, and Wells Fargo Securities will be the joint book-running managers for the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.